Wilmington, DE -- (SBWIRE) -- 09/09/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Celgene Corporation (NASDAQ:CELG) and Cree, Inc. (NASDAQ:CREE).
Celgene Corporation (NASDAQ:CELG) a company that discovers, develops, and commercializes therapies for cancer and immune-inflammatory related diseases in the United States and Europe is currently up (+0.64%) on 1,078,051 shares traded. Celgene Corporation (NASDAQ:CELG) is currently up (+108.48%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Celgene Corporation (NASDAQ:CELG)
Cree, Inc. (NASDAQ:CREE) a company that develops, manufactures, and sells lighting-class light emitting diode, lighting, and semiconductor products for power and radio-frequency applications in the United States, China, Europe, South Korea, Japan, Malaysia, and Taiwan is currently up (+2.66%) on 989,917 shares traded after The National Aeronautics and Space Administration headquarters, a leased facility in Washington, D.C., has been outfitted with energy-saving CR Series LED Troffers by Cree, Inc. Cree, Inc. (NASDAQ:CREE) is currently up (+134.53%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Cree, Inc. (NASDAQ:CREE)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)